These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21821732)

  • 21. Efficacy and safety of anticoagulation for atrial fibrillation in patients with cirrhosis: A systematic review and meta-analysis.
    Chokesuwattanaskul R; Thongprayoon C; Bathini T; Torres-Ortiz A; O'Corragain OA; Watthanasuntorn K; Lertjitbanjong P; Sharma K; Prechawat S; Ungprasert P; Kröner PT; Wijarnpreecha K; Cheungpasitporn W
    Dig Liver Dis; 2019 Apr; 51(4):489-495. PubMed ID: 30594462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bleeding risk factors affecting warfarin therapy in the elderly with atrial fibrillation.
    Darnell SW; Davis SC; Whitcomb JJ; Manfredi JA; McLaurin BT
    Dimens Crit Care Nurs; 2014; 33(2):57-63. PubMed ID: 24496251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
    Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial Fibrillation Patients Treated With Long-Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long-Term Warfarin for Other Indications.
    Bunch TJ; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Jacobs V; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27402230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic.
    Lee SI; Sayers M; Lip GY; Lane DA
    Int J Clin Pract; 2015 Nov; 69(11):1341-8. PubMed ID: 26234557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).
    Rost NS; Giugliano RP; Ruff CT; Murphy SA; Crompton AE; Norden AD; Silverman S; Singhal AB; Nicolau JC; SomaRaju B; Mercuri MF; Antman EM; Braunwald E;
    Stroke; 2016 Aug; 47(8):2075-82. PubMed ID: 27387994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of anticoagulation for atrial fibrillation and reasons for its non-use at a Veterans Affairs medical center.
    Bradley BC; Perdue KS; Tisdel KA; Gilligan DM
    Am J Cardiol; 2000 Mar; 85(5):568-72. PubMed ID: 11078269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physicians' attitudes toward anticoagulant therapy in patients with chronic atrial fibrillation.
    Maeda K; Sakai T; Hira K; Sato TS; Bito S; Asai A; Hayano K; Matsumura S; Yamashiro S; Fukui T
    Intern Med; 2004 Jul; 43(7):553-60. PubMed ID: 15335179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization of antithrombotic therapy for stroke prevention in atrial fibrillation: a cross-sectional baseline analysis in general practice.
    Bajorek B; Magin PJ; Hilmer S; Krass I
    J Clin Pharm Ther; 2016 Aug; 41(4):432-40. PubMed ID: 27338004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
    Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
    JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Underuse of anticoagulation in patients with atrial fibrillation.
    Vallakati A; Lewis WR
    Postgrad Med; 2016; 128(2):191-200. PubMed ID: 26666288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What are the barriers to warfarin use in atrial fibrillation?: Development of a questionnaire.
    Ingelgård A; Hollowell J; Reddy P; Gold K; Tran K; Fitzmaurice D
    J Thromb Thrombolysis; 2006 Jun; 21(3):257-65. PubMed ID: 16683218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Why is warfarin underused for stroke prevention in atrial fibrillation? A detailed review of electronic medical records.
    Rosenman MB; Baker L; Jing Y; Makenbaeva D; Meissner B; Simon TA; Wiederkehr D; Deitelzweig S
    Curr Med Res Opin; 2012 Sep; 28(9):1407-14. PubMed ID: 22746356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stroke prevention in elderly patients with atrial fibrillation.
    Lew SJ; Lim JK
    Singapore Med J; 2002 Apr; 43(4):198-201. PubMed ID: 12188065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stroke prevention in atrial fibrillation: physicians' attitudes to anticoagulation in older people.
    Vasishta S; Toor F; Johansen A; Hasan M
    Arch Gerontol Geriatr; 2001; 33(3):219-26. PubMed ID: 15374018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HRS/NSA 2014 survey of atrial fibrillation and stroke: Gaps in knowledge and perspective, opportunities for improvement.
    Frankel DS; Parker SE; Rosenfeld LE; Gorelick PB
    Heart Rhythm; 2015 Aug; 12(8):e105-13. PubMed ID: 25981149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective Evaluation and Assessment of Therapies in AF (TREAT-AF) study.
    Turakhia MP; Hoang DD; Xu X; Frayne S; Schmitt S; Yang F; Phibbs CS; Than CT; Wang PJ; Heidenreich PA
    Am Heart J; 2013 Jan; 165(1):93-101.e1. PubMed ID: 23237139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attitudes of Japanese cardiologists toward anticoagulation for nonvalvular atrial fibrillation and reasons for its underuse.
    Inoue H; Nozawa T; Okumura K; Iwasa A; Lee JD; Shimizu A; Hayano M; Yano K
    Circ J; 2004 May; 68(5):417-21. PubMed ID: 15118281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
    Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.